The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 05, 2023
Filed:
Dec. 31, 2020
Applicant:
Taris Biomedical Llc, Lexington, MA (US);
Inventor:
Heejin Lee, Bedford, MA (US);
Assignee:
TARIS Biomedical LLC, Lexington, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61M 31/00 (2006.01); A61J 1/00 (2023.01); A61L 31/16 (2006.01); A61J 1/03 (2023.01); A61K 9/00 (2006.01); A61K 9/20 (2006.01); A61K 45/06 (2006.01); A61L 31/06 (2006.01); A61L 31/14 (2006.01); B29C 48/11 (2019.01); B29C 48/21 (2019.01); B29C 48/00 (2019.01); B29K 105/00 (2006.01); B29C 48/09 (2019.01); B29C 48/19 (2019.01); B29K 75/00 (2006.01); B29L 31/00 (2006.01);
U.S. Cl.
CPC ...
A61M 31/002 (2013.01); A61J 1/00 (2013.01); A61J 1/03 (2013.01); A61K 9/0034 (2013.01); A61K 9/20 (2013.01); A61K 45/06 (2013.01); A61L 31/06 (2013.01); A61L 31/14 (2013.01); A61L 31/16 (2013.01); A61M 2207/00 (2013.01); A61M 2210/1085 (2013.01); B29C 48/0022 (2019.02); B29C 48/09 (2019.02); B29C 48/11 (2019.02); B29C 48/19 (2019.02); B29C 48/21 (2019.02); B29C 2793/009 (2013.01); B29K 2075/00 (2013.01); B29K 2105/0035 (2013.01); B29K 2995/0092 (2013.01); B29L 2031/753 (2013.01);
Abstract
Drug delivery devices having a drug-permeable component and methods of making and using the same are provided. Drug delivery devices include a housing having a first and second wall structures that are adjacent one another and together form a tube defining a drug reservoir lumen. The second wall structure, or both the first wall structure and the second wall structure, are permeable to water, and the first wall structure is impermeable to the drug while the second wall structure is permeable to the drug, such that the drug is releasable in vivo by diffusion through the second wall structure.